EXAGEN Inc. Reports Q2 2026 Financial Results

What Happened

• On August 4, 2026, EXAGEN Inc. (XGN) announced its financial results for the three and six months ended June 30, 2026. The company furnished a press release summarizing those results as Exhibit 99.1 to the Form 8-K filed that day.

Key Details

• Date filed: August 4, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: three and six months ended June 30, 2026.
• Press release: furnished as Exhibit 99.1 to the 8-K.
• Interactive data: Cover Page Interactive Data File included (Inline XBRL).

Why It Matters

• Quarterly results provide investors up-to-date information on EXAGEN’s revenue, expenses, and overall financial health for Q2 2026; these results can affect valuation and near-term stock performance.
• The 8-K furnishes the company’s initial public summary of performance for the period; investors should review the Exhibit 99.1 press release and any subsequent SEC filings (e.g., 10-Q) for full financial statements, metrics (revenue, net loss/profit, cash position), and management commentary before making investment decisions.